---
$id: https://graph.org.ai/products/commodity/51171834
$type: Product
source: UNSPSC
code: "51171834"
title: "Cannabinol or nabiximols or tetrahydrocannabinol"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cannabinol or nabiximols or tetrahydrocannabinol

**UNSPSC Code**: 51171834
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiemetic agent with the molecular formula C21H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7UYP6MC9GH, chemically known as 6,6,9-trimethyl-3-pentyl-6h-dibenzo(b,d)pyran-1-ol but generally known as cannabinol, which bears US NIH Compound Identifier 2543. Cannabinol most often comes in base, methyl, and tert-butyldimethylsilyl ether forms. European Medicines Agency schedules Cannabinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06074MIG. The term CANNABINOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). CANNABINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cannabinol under HS 29329985 and SITC 51569. As of Q4 2014, CANNABINOL remains the US FDA Preferred Term for this commodity. Cannabinol bears US NLM identifiers UMLS ID C0006865 and NCI Concept Code C84510. SMILES: O1C(C2C(C3C1CC(CCCCC)CC3O)CC(CC2)C)(C)C.

